Search Results - "Culler, M. D"
-
1
Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classified as partially responsive to somatostatin analog therapy
Published in European journal of endocrinology (01-07-2005)“…Objective: This study compared the potency of a somatostatin receptor (sstr)2–sstr5 analog, BIM-23244, of an sstr2-dopamine D2 receptor (sstr2-DAD2) molecule,…”
Get full text
Journal Article -
2
Demonstration of Enhanced Potency of a Chimeric Somatostatin-Dopamine Molecule, BIM-23A387, in Suppressing Growth Hormone and Prolactin Secretion from Human Pituitary Somatotroph Adenoma Cells
Published in The journal of clinical endocrinology and metabolism (01-12-2002)“…In acromegaly, the combination of somatostatin (SS) and dopamine (DA) agonists has been shown to enhance suppression of GH secretion. In the present study, a…”
Get full text
Journal Article -
3
Somatostatin Dramatically Stimulates Growth Hormone Release from Primate Somatotrophs Acting at Low Doses Via Somatostatin Receptor 5 and Cyclic AMP
Published in Journal of neuroendocrinology (01-03-2012)“…Somatostatin and cortistatin have been shown to act directly on pituitary somatotrophs to inhibit growth hormone (GH) release. However, previous results from…”
Get full text
Journal Article -
4
Somatostatin Inhibits Tumor Angiogenesis and Growth via Somatostatin Receptor-3-Mediated Regulation of Endothelial Nitric Oxide Synthase and Mitogen-Activated Protein Kinase Activities
Published in Endocrinology (Philadelphia) (01-04-2003)“…Somatostatin was reported to inhibit Kaposi’s sarcoma (KS) cell (KS-Imm) xenografts through an antiangiogenic activity. Here, we show that somatostatin blocks…”
Get full text
Journal Article -
5
Somatostatin and dopamine receptor interaction in prostate and lung cancer cell lines
Published in Journal of endocrinology (01-12-2010)“…Somatostatin analogues inhibit in vitro cell proliferation via specific membrane receptors (SSTRs). Recent studies on transfected cell lines have shown a…”
Get full text
Journal Article -
6
Endogenous Ghrelin Regulates Episodic Growth Hormone (GH) Secretion by Amplifying GH Pulse Amplitude: Evidence from Antagonism of the GH Secretagogue-R1a Receptor
Published in Endocrinology (Philadelphia) (01-09-2005)“…Ghrelin was purified from rat stomach as an endogenous ligand for the GH secretagogue (GHS) receptor. As a GHS, ghrelin stimulates GH release, but it also has…”
Get full text
Journal Article -
7
BIM-23244, a somatostatin receptor subtype 2- and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomas
Published in The journal of clinical endocrinology and metabolism (2001)“…Although both somatostatin receptor subtype 2 (SSTR2) and SSTR5 messenger ribonucleic acid (mRNA) are consistently expressed in GH-secreting adenomas, SSTR2…”
Get full text
Journal Article -
8
Characterization and sub-cellular localization of SS1R, SS2R, and SS5R in human late-stage prostate cancer cells: Effect of mono- and bi-specific somatostatin analogs on cell growth
Published in Molecular and cellular endocrinology (15-02-2014)“…•Somatostatin system plays a significant role in the progression of human prostate cancer.•Activation of SS1R and SS2R/SS5R leads to relevant antiproliferative…”
Get full text
Journal Article -
9
Role of the corticotropin-releasing factor receptor type 2 in the control of food intake in mice: a meal pattern analysis
Published in The European journal of neuroscience (01-10-2007)“…The actions of corticotropin‐releasing factor (CRF) and related peptides are mediated by two receptors (CRF1 and CRF2). The respective role of each subtype in…”
Get full text
Journal Article -
10
Human somatostatin receptor subtypes in acromegaly : Distinct patterns of messenger ribonucleic acid expression and hormone suppression identify different tumoral phenotypes
Published in The journal of clinical endocrinology and metabolism (01-02-2000)“…Recently, studies using somatostatin (SRIF) analogs preferential for either the SRIF receptor 2 (SSTR2) or the SSTR5 subtype demonstrated a variable…”
Get full text
Journal Article -
11
The effect of emulsifying salts on the turbidity of a diluted milk system with varying pH and protein concentration
Published in Journal of dairy science (01-06-2017)“…Solutions of 10 commonly used emulsifying salts (ES) listed in the Code of Federal Regulations (21CFR133.179) for pasteurized process cheese were tested for…”
Get more information
Journal Article -
12
Quantitative and Functional Expression of Somatostatin Receptor Subtypes in Human Prolactinomas
Published in The journal of clinical endocrinology and metabolism (01-09-1999)“…ABSTRACTRecently, it was demonstrated that somatostatin analogs preferential for the SSTR5 subtype suppress PRL release from prolactinoma cell cultures by…”
Get full text
Journal Article -
13
Somatostatin-dopamine chimeras: a novel approach to treatment of neuroendocrine tumors
Published in Hormone and metabolic research (01-11-2011)“…A combination of basic research observations concerning the interaction of somatostatin (SST) and dopamine (DA) receptors, and clinical reports of enhanced…”
Get more information
Journal Article -
14
Characterization of New Selective Somatostatin Receptor Subtype-2 (sst2) Antagonists, BIM-23627 and BIM-23454. Effects of BIM-23627 on GH Release in Anesthetized Male Rats after Short-Term High-Dose Dexamethasone Treatment
Published in Endocrinology (Philadelphia) (01-04-2002)“…We here report a pharmacological characterization of two new somatostatin (SS) receptor subtype-2 (sst2) selective antagonists by evaluating their GH-releasing…”
Get full text
Journal Article -
15
Dopamine receptor subtype 2 and somatostatin receptor subtype 5 expression influences somatostatin analogs effects on human somatotroph pituitary adenomas in vitro
Published in Journal of molecular endocrinology (01-10-2005)“…Dopamine (DA) and somatostatin (SRIF) receptor agonists inhibit growth hormone (GH) secretion by pituitary adenomas. We investigated DA subtype 2 receptor…”
Get full text
Journal Article -
16
Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation
Published in The Journal of clinical investigation (15-02-1997)“…Somatostatin (SRIF), a hypothalamic inhibitor of pituitary growth hormone (GH) and thyroid-stimulating hormone (TSH) secretion, binds to five distinct receptor…”
Get full text
Journal Article -
17
Novel ghrelin analogs with improved affinity for the GH secretagogue receptor stimulate GH and prolactin release from human pituitary cells
Published in European journal of endocrinology (01-12-2004)“…OBJECTIVE: Ghrelin, a recently identified 28-amino acid peptide is a potent GH secretagogue (GHS) produced predominantly by the stomach. Ghrelin stimulates GH…”
Get full text
Journal Article -
18
Regulation of insulin and glucagon secretion from rat pancreatic islets in vitro by somatostatin analogues
Published in Regulatory peptides (10-01-2007)“…Somatostatin is an inhibitor of hormone secretion through specific receptors (sst 1–5). The aim of this study was to investigate the putative regulatory role…”
Get full text
Journal Article -
19
The effect of selective sst1, sst2, sst5 somatostatin receptors agonists, a somatostatin/dopamine (SST/DA) chimera and bromocriptine on the “clinically non-functioning” pituitary adenomas in vitro
Published in Life sciences (1973) (11-01-2006)“…The aim of the work was to investigate the effects of somatostatin analogs acting selectively on sst1 (BIM-23926), sst2 (BIM-23120) and sst5 (BIM-23206)…”
Get full text
Journal Article -
20
Expression and function of somatostatin receptor subtype 1 in human growth hormone secreting pituitary tumors deriving from patients partially responsive or resistant to long-term treatment with somatostatin analogs
Published in Neuroendocrinology (01-03-2004)“…The role of somatostatin (SS) receptor subtype 1 (SSTR(1)) in mediating the inhibitory effect of SS on growth hormone (GH) secreting pituitary tumors has been…”
Get more information
Journal Article